Ultralife (NASDAQ:ULBI - Get Free Report) posted its quarterly earnings data on Friday. The technology company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.02), RTT News reports. Ultralife had a return on equity of 7.92% and a net margin of 5.44%. The company had revenue of $50.75 million during the quarter, compared to analysts' expectations of $54.50 million. During the same quarter last year, the company earned $0.21 earnings per share.
Ultralife Stock Up 4.8%
Shares of NASDAQ:ULBI traded up $0.24 during trading on Monday, reaching $5.29. The stock had a trading volume of 64,185 shares, compared to its average volume of 70,636. The firm's 50-day simple moving average is $4.94 and its 200 day simple moving average is $6.66. Ultralife has a one year low of $4.07 and a one year high of $12.63. The company has a market capitalization of $87.99 million, a P/E ratio of 9.62 and a beta of 0.77. The company has a current ratio of 3.30, a quick ratio of 1.62 and a debt-to-equity ratio of 0.04.
Institutional Investors Weigh In On Ultralife
An institutional investor recently raised its position in Ultralife stock. Bank of America Corp DE boosted its position in shares of Ultralife Co. (NASDAQ:ULBI - Free Report) by 30.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,067 shares of the technology company's stock after buying an additional 2,836 shares during the quarter. Bank of America Corp DE owned approximately 0.07% of Ultralife worth $90,000 at the end of the most recent reporting period. Institutional investors own 30.68% of the company's stock.
Analyst Ratings Changes
Separately, StockNews.com lowered Ultralife from a "buy" rating to a "hold" rating in a research note on Tuesday, March 18th.
Check Out Our Latest Analysis on Ultralife
About Ultralife
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Featured Stories
Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
